Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.CME information and select publications here.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Hematologic Oncology Update
Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
Get summaries like this every morning.
Free AI-powered recaps of Hematologic Oncology Update and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.